Ethyl 2-Cyano-4,4-Diethoxybutanoate (CAS 52133-67-2): An Important Intermediate in Tofacitinib Synthesis
The development of modern pharmaceutical compounds relies heavily on high-quality chemical intermediates. One such compound, Ethyl 2-cyano-4,4-diethoxybutanoate (CAS No. 52133-67-2), plays a significant role in the synthesis of Tofacitinib intermediates and supports efficient drug development processes.
Ethyl 2-cyano-4,4-diethoxybutanoate is valued for its chemical stability and suitability for multi-step organic synthesis. These characteristics make it a preferred intermediate for pharmaceutical manufacturers aiming for consistent performance and reproducibility in large-scale production.
Tofacitinib is widely used in advanced therapeutic applications, and the reliability of its intermediates is essential for maintaining product quality. The use of well-manufactured intermediates such as Ethyl 2-cyano-4,4-diethoxybutanoate contributes to smoother synthesis routes and improved process efficiency.
Manufacturers and research organizations often seek suppliers that follow strict quality standards and provide dependable supply chains. Companies like Vidgastech focus on delivering pharmaceutical intermediates that meet global quality expectations, ensuring consistency across research and industrial applications.
As the pharmaceutical industry continues to evolve, the demand for high-purity intermediates will remain strong. Ethyl 2-cyano-4,4-diethoxybutanoate continues to be a valuable building block in Tofacitinib-related synthesis, supporting innovation and progress in drug manufacturing.
Website:https://www.vidgastech.com










